Position in ALKS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$436,974
New position
Shares Held
8,340
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#51
of 146 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Abel Hall, LLC holds $4,102,863 across 16 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
40,603 | $650,866 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
15,724 | $545,151 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
3,992 | $442,872 | |
| 4 | ALKS |
Alkermes plc.
This page
|
8,340 | $436,974 | |
| 5 | LQDA |
Liquidia Corp
|
4,705 | $375,129 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
6,049 | $285,936 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
11,358 | $196,606 | |
| 8 | VTRS |
Viatris Inc
|
12,123 | $192,513 |
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $436,974 | 8,340 | Shares | Sole | 2026-07-24 | |
| No filing history on record for this holder in this stock. | ||||||